Houston, Texas — The National Institutes of Health is funding the study of a new research project that will use a new technique to study how microbes in the human gut impact health.
The new technique, which uses nanoparticles to measure how well the human microbiome functions, uses a novel genetic technique called deep sequencing to collect samples from healthy people and then compare them to those with bacteria that are associated with the common cold.
The results are expected to be published next year, according to a statement from the NIH.
The study, called “The Human Microbiome Project,” will analyze the microbes in people’s guts.
Researchers hope to use this information to develop treatments for diseases like asthma, type 2 diabetes, obesity, cancer, and Alzheimer’s disease.
The project is a collaboration between UC San Diego, the University of Houston, and the University College London.
The UC San Francisco Institute of Technology will be responsible for development of the technology.
The researchers will analyze how the microbiome affects a range of diseases, including asthma, obesity and cancer, in healthy people, and those with common colds.
They hope to learn how the same microbiome may be linked to the disease.
“The microbiome is the collective environment of the human body,” said David A. Laughlin, Ph.
D., an associate professor of microbiology and immunology at UC San José, who was not involved in the research.
“It’s the environment that we live in.”
The team will also investigate how bacteria can interact with the immune system to combat disease, and how they can influence the human immune system, Laughlin said.
The scientists hope the results could lead to new therapies for the common diseases.
The NIH has funded the study for more than a decade.
It is part of a larger effort by the agency to expand its microbiome research and develop new treatments.